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Council score correlated moderately but significantly with 
W max (p  ! 0.05 each). The maximum correlation gained by 
including 6MWD and further parameters in the prediction 
equations was r = 0.76 in patients with obstructive lung func-
tion impairment and r = 0.61 in asbestosis patients. The re-
sidual standard deviations of W max predicted by the calcu-
lated equations ranged between 20 and 28 W, and the 
95% prediction intervals of W max ranged between  8 47 and 
 8 65 W.  Conclusions: A reliable prediction of individual W max 
by 6MWD or related measures and therefore a replacement 
by other tests is not possible. Nevertheless, it may be useful 
for the comparison of average values in epidemiological and 
clinical studies. 
 
Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Exercise training is a recognized therapy option in pa-
tients with chronic respiratory diseases regardless of un-
derlying causes  [1, 2] . Within rehabilitation programs  [3] , 
endurance training is usually conducted on cycle ergom-
eters at a work rate of at least 60% of individual maximal 
work capacity  [3] . The assessment of maximal work ca-
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 Abstract 
 Background: In patients with chronic lung diseases, the 
work rate for endurance training is calculated by the maxi-
mal work rate (W max ). Because the assessment bears side ef-
fects, a prediction by easier accessible tests would be of 
practical use.  Objective: We addressed the reliability of pre-
dicting W max on the basis of the 6-min walk distance (6MWD) 
test and a set of further parameters in patients with different 
lung diseases.  Methods: Baseline data of a longitudinal 
study including 6MWD, W max , peripheral muscle force, lung 
function, fat-free mass and dyspnea (Modified Medical Re-
search Council score) of 255 men with occupational lung 
 diseases (104 asthma, 69 asbestosis, 42 silicosis, 40 chronic 
obstructive pulmonary disease) were evaluated.  Results: 
6MWD correlated with W max (r = 0.51, p  ! 0.05). The product 
of 6MWD and body weight, in particular fat-free mass, led to 
an improvement in the correlation of W max with 6MWD.
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pacity requires special equipment and well-trained staff, 
is expensive, time consuming and bears the risk of side 
effects. 
 Therefore, a prediction of the maximal work rate 
(W max ) by more easily assessed measures would be of 
practical relevance. Regarding patients with chronic ob-
structive pulmonary disease (COPD), equations for pre-
dicting W max from the 6-min walk distance (6MWD) test 
have been presented  [4–8] . One study also offered an 
equation for patients with lung fibrosis  [6] . Four of these 
studies were based on small samples. To evaluate the ap-
plicability of prediction, larger study groups with differ-
ent respiratory diseases are needed. 
 Based on these considerations, we reanalyzed the 
baseline data from a large study on the efficacy of reha-
bilitation  [9] . We aimed to quantify the correlations of 
W max with other measures and to assess the maximal re-
liability of individual prediction by including a broad 
range of predictors. For clarification, we also compared 
the results with existing prediction equations for W max .
 Methods 
 Study Design and Subjects 
 Subjects were recruited within a longitudinal clinical study on 
the efficacy of pulmonary rehabilitation in 287 patients with oc-
cupational lung diseases. Baseline data before intervention were 
reanalyzed in a subpopulation of 255 men. 
 This study was approved by the German Social Accident In-
surance according to official ethic regulations (project No. 
FFFB0094). Patients gave their informed consent.
 The inclusion criteria were: recognized occupational respira-
tory disease diagnosed as asthma, asbestosis, silicosis or COPD in 
coal miners; functional impairment leading to a reduction in 
earning capacity by 20–50%, age  ! 75 years; no rehabilitation in 
the previous 2 years; maximum exercise capacity of at least 40 W; 
no progressive malignant diseases; clinically stable. 
 Assessments included height, age, weight, body fat by near-
infrared light measurement (Futrex 6100 XL, Futrex Inc., USA), 
spirometry (Master Screen Body, Care Fusion Germany), periph-
eral muscle force, 6MWD, W max and dyspnea at rest [Modified 
Medical Research Council (MMRC) questionnaire].
 The 6MWD was determined 2 times on the first day (resting 
time of  6 40 min in between) and once on the following day ac-
cording to American Thoracic Society guidelines  [10] . W max was 
assessed by incremental cycle ergometry test (Master Screen CPX, 
Care Fusion Germany; e-Bike Basic PC Plus-Ctrl, Ergoline GmbH, 
Germany). After a resting period of 3 min while already sitting on 
the ergometer, patients started cycling at a work rate of 30 W. The 
work rate was increased every 2 min by 20 W until symptom lim-
itation. W max was defined as the highest work rate achieved for at 
least 30 s.
 Quadriceps muscle force was measured by the ‘DigiMax-Mus-
kelfunktion-Testcenter’ (DigiMax, MechaTronics, Hamm, Ger-
many) and handgrip force by a hydraulic hand dynamometer (JA-
MAR, Lafayette Instrument, USA); the best value of 3 tests was 
taken. Results were expressed as the sum of both extremities in 
kilograms.
 Statistical Analysis  
 For data description, absolute and relative frequencies as well 
as mean values, standard deviations (SDs) and ranges were com-
puted. Subgroups were compared with each other using one-way 
analysis of variance (ANOVA) and   2 tests of contingency tables. 
If overall differences turned out to be statistically significant, ap-
propriate post hoc multiple comparisons were made using the 
Student-Newman-Keuls multiple range test. The total group of 
patients and the subgroups with asthma, asbestosis, silicosis or 
COPD, or the pooled data of asthma, silicosis and COPD were 
analyzed. The adequacy and admissibility of ANOVA was checked 
by standard procedures regarding data distributions and resid-
uals.
 Multiple stepwise linear regression analysis of W max was used 
to identify the predictors. To allow practical conclusions, the ac-
curacy of prediction was expressed not only by the explained vari-
ance and Pearson correlation coefficients but also by the residual 
SD of the prediction and the 95% prediction intervals which refer 
to the prediction of the value of a newly recruited individual who 
was not part of the group used for analysis. The level of statistical 
significance was assumed as p = 0.05. All calculations were per-
formed with the software SPSS 19. 
 Results 
 The present study is based on data of the baseline ex-
amination of the subgroup of men (n = 255): 104 with 
asthma, 42 with silicosis, 69 with asbestosis and 40 with 
COPD; the subgroup of women was excluded, being too 
small to allow statistically reliable conclusions. The study 
was conducted from March 2007 to May 2010. Charac-
teristics of study subjects are given in  table 1 . 
 6MWD Test 
 The comparison of 6MWD values of the three tests on 
2 days is shown in  table 2 . 
 Upon statistical testing, the mean difference between 
the first and second test (mean  8 SD, 16  8 34 m) turned 
out to be significantly different from the difference be-
tween the second and third test (6  8 42 m). We consid-
ered the first test as run-in test and selected the individ-
ual best test out of the second and third test. 
 The results for asthma, silicosis, asbestosis and COPD 
are shown in  table 2 . 6MWD was shorter in the COPD 
and silicosis groups compared to the two other groups 
(ANOVA, p  ! 0.05 each). The mean 6MWD in the total 
group was 502 m (range 230–670).
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 Maximal Work Capacity 
 ANOVA revealed significantly higher values in asth-
ma patients (p  ! 0.05). Data are given in  table 3 . The mean 
maximal work capacity in the total population was 112 W 
(range 40–230).
 Correlation between 6MWD and W max 
 The total population showed a significant correlation 
(r = 0.51, p  ! 0.05) between 6MWD and W max .  Figure 1 
displays the relationships in the disease groups. When re-
gression lines were tested for differences by pairwise com-
parisons, intercepts and slopes proved to be similar in the 
silicosis, asthma and COPD subgroups but different in the 
asbestosis subgroup (p  ! 0.05). Based on these results, sil-
icosis, asthma and COPD were analyzed together called 
‘obstructive group’ ( table 1 ). The asbestosis group was an-
alyzed separately. Regression lines and their confidence 
intervals for both groups are shown in  figure 2 .
 Correlation of Further Parameters with W max 
 Table  4 shows the single correlations between W max 
and additional parameters. To identify the best combina-
tions of predictors, we defined the entities ‘walking test’, 
‘lung function’ and ‘extremity muscle force’.
 • Walking test: 6MWD, 6-min walk work (6MWW) cal-
culated by multiplying 6MWD in km and body weight 
in kg, or 6-min walk fat-free mass (6MWFFM), the 
product of 6MWD in km and FFM in kg.  
 • Lung function: forced expiratory volume in 1 s (FEV 1 ) 
in  liters, forced vital capacity (FVC) in liters, their per-
cent predicted values, or their ratio in percent (Tiffe-
neau quotient). 
 • Extremity muscle force: handgrip or quadriceps mus-
cle force. 
 To deal with the colinearity, multiple linear regression 
was performed with all possible combinations of just one 
parameter from each above-mentioned entity to identify 
the best predictor.
 Prediction Models for W max in Different Groups of 
Diseases 
 In the obstructive group, the maximal overall corre-
lation reached r = 0.758. In the stepwise multivariate 
analysis, the anthropometric parameters turned out 
to become insignificant and were excluded, while 
6MWFFM, FVC, MMRC and quadriceps muscle force 
remained significant (p  ! 0.05 each). Including these 
measures, the correlation was r = 0.748 and the predic-
tion equation is:
Table 1. C haracteristics of study subjects
Asthma
(n = 104)
Silicosis
(n = 42)
COPD
(n = 40)
Obstructive group
(n = 186)
Asbestosis
(n = 69)
Age, years 58 (8) 64 (6) 68 (3) 61 (8) 63 (5)
Height, m 1.73 (0.06) 1.74 (0.05) 1.73 (0.06) 1.73 (0.06) 1.73 (0.07)
Weight, kg 87.6 (15.6) 85.2 (13.7) 87.7 (15.4) 87.1 (15.1) 87.1 (13.2)
FFM, kg 65.0 (7.2) 63.0 (4.4) 63.5 (6.6) 64.4 (10.9) 63.4 (6.5)
BMI 29.1 (4.7) 28.0 (3.7) 29.3 (5.0) 28.9 (4.6) 30.0 (3.8)
FEV1, l 2.57 (0.84) 2.48 (0.55) 2.27 (0.55) 2.48 (0.74) 2.35 (0.61)
FVC, l 3.77 (0.99) 3.62 (0.59) 3.47 (0.72) 3.68 (0.87) 3.19 (0.73)
FEV1, %pred. 79.4 (22.4) 80.9 (16.6) 78.0 (18.0) 79.4 (20.3) 77.8 (19.8)
FVC, %pred. 92.3 (20.6) 91.7 (14.7) 91.7 (18.7) 92.3 (18.9) 81.8 (17.6)
FEV1/VC, % 68.0 (14.6) 67.5 (10.9) 64.3 (8.8) 67.1 (12.8) 74.2 (12.8)
Handgrip force, kg 75.6 (18.0) 72.2 (18.5) 67.5 (14.8) 73.1 (17.7) 70.6 (18.2)
Quadriceps force, kg 68.3 (23.6) 58.3 (20.8) 55.2 (25.0) 63.2 (23.9) 61.6 (21.3)
MMRC, nominal scale 1.88 (1.02) 2.02 (1.00) 1.93 (1.10) 1.92 (1.03) 1.84 (0.98)
D ata are means, with SDs in parentheses. BMI = Body mass index.
Table 2. C omparison of 6MWD results of the three tests on 2 days
n %
Best result in the first test 13 5
Best result in the second test 62 24
Best result in the third test 124 49
Same result in all tests 13 5
Same and best result in the first and second test 6 2
Same and best result in the second and third test 34 13
Same and best result in the first and third test 3 1
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 (a) W max pred. = –6.117 + 2.491  6MWFFM (km  kg) – 
5.926  MMRC + 10.118  FVC (l) + 0.232  quadriceps mus-
cle force (kg).
 Measurement of quadriceps muscle force is not rou-
tinely available. We excluded this predictor despite being 
statistically significant. The correlation was r = 0.737 cor-
responding to the equation:
 (b) W max pred. = –1.786 + 2.793  6MWFFM (km  kg) – 
6.723  MMRC + 10.748  FVC (l).
 Values of FFM might not be available. The next best 
model was based on the 6MWW, with a correlation of 
r = 0.721 and the following equation:
 (c) W max pred. = 9.177 + 1.621  6MWW (km  kg) – 
8.121  MMRC + 13.768  FVC (l).
 When substituting 6MWW by 6MWD, the correla-
tion was reduced to r = 0.677: 
 (d) W max pred. = 2.888 + 0.140  6MWD (m) – 
7.533  MMRC + 15.224  FVC (l).
 In the asbestosis group, the maximal overall correla-
tion reached r = 0.623. In the combined, stepwise model, 
quadriceps muscle force and body mass index were ex-
cluded, being insignificant, whereas 6MWD, FVC and 
MMRC remained significant (p  ! 0.05 each). The corre-
sponding correlation was r = 0.607. The equation was as 
follows:
 (e) W max pred. = 57.287 + 0.072  6MWD (m) – 
9.456  MMRC + 9.676  FVC (l).
 Residuals and Prediction Intervals 
 In the obstructive group, SDs of the residuals ranged 
between 25.678 for equation (a) and 28.108 for equation 
(d); in the asbestosis group, the SD was 20.859. We also 
computed 95% prediction intervals that describe the pre-
diction for a newly included patient. Prediction intervals 
were calculated with 6MWD being the only independent 
variable in linear regression to ensure the comparability 
between regressions and the literature. Details concern-
ing the single disease groups are given in  table 5 . The 95% 
prediction intervals are also graphically demonstrated in 
 figure 1 , in addition to the individual values and the re-
gression line.
Table 3.  Results of 6MWD and incremental cycle ergometry test
Asthma
(n = 104)
Silicosis
(n = 42)
COPD
(n = 40)
Obstructive group
(n = 186)
Asbestosis
(n = 69)
Distance, m 531 (86) 468 (70) 444 (87) 498 (91) 514 (96)
Walk work, kmkg 46.3 (10.2) 39.7 (7.6) 38.5 (8.6) 43.1 (10.0) 44.5 (9.1)
Heart rate before exercise, bpm 80 (13) 77 (12) 78 (12) 79 (13) 82 (16)
Heart rate at the end of the test, bpm 112 (17) 115 (18) 112 (15) 112 (17) 113 (17)
SO2 before exercise, % 94 (2) 94 (1) 94 (2) 94 (2) 94 (2)
SO2 at the end of the test, % 94 (3) 91 (3) 91 (4) 93 (3) 91 (5)
Wmax, W 120 (41) 106 (31) 106 (34) 114 (38) 107 (26)
Heart rate before exercise, bpm 82 (13) 78 (13) 80 (13) 81 (13) 83 (17)
Heart rate Wmax, bpm 132 (21) 126 (24) 125 (23) 129 (22) 127 (19)
D ata are means, with SDs in parentheses. SO2 = Peripheral oxygen saturation.
Table 4. S ingle correlations of Wmax and further variables
Variable Obstructive 
group (n = 186)
Asbestosis group 
(n = 69)
r p r p
6MWD, m 0.550 <0.01 0.452 <0.01
6MWW, kmkg 0.606 <0.01 0.322 <0.01
6MWFFM, kmkg 0.679 <0.01 0.049 0.688
Body weight, kg 0.213 <0.01 0.153 0.210
Body height, m 0.321 <0.01 0.134 0.272
Age, years 0.338 <0.01 0.210 0.083
BMI 0.105 0.135 0.281 0.020
FFM, kg 0.351 <0.01 0.015 0.905
MMRC, nominal scale 0.432 <0.01 0.456 <0.01
Handgrip force, kg 0.474 <0.01 0.224 0.064
Quadriceps force, kg 0.429 <0.01 0.268 0.026
FEV1, l 0.506 <0.01 0.301 0.012
FEV1, %pred. 0.369 <0.01 0.225 0.063
FVC, l 0.542 <0.01 0.335 <0.01
FVC, %pred. 0.381 <0.01 0.257 0.033
FEV1/FVC, % 0.130 0.076 0.135 0.267
r  = Correlation coefficient (Pearson); BMI = body mass index.
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 Comparison with Prediction Equations from the 
Literature 
 Figure 3 a illustrates the residuals of predicted W max of 
the obstructive group in dependence of the 6MWD, using 
equation (a) as given above. For comparison, we applied the 
four equations for estimating W max as found in the litera-
ture  [4–7] to the data of our population. The residuals of 
these calculations are shown in  figure 3 b–e. The same was 
done for the asbestosis group using equation (e) and the 
one equation from the literature  [6] for estimating W max in 
lung fibrosis patients, as demonstrated in  figure 4 b.
 Discussion 
 Training of exercise capacity is an important issue in 
the rehabilitation of patients with chronic lung diseases 
 [11] . Commonly, the intensity of training is calculated by 
the maximal work capacity. The prediction of maximal 
work capacity by more easily assessed measures would be 
of practical value. 
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 Fig. 1.  a–d Relationship between 6MWD 
and W max . Regression lines (solid lines) 
and their equations are given for the four 
disease groups, as well as 95% prediction 
intervals (dashed lines) for a newly includ-
ed individual. 
200 400 600 800
6MWD (m)
W
m
ax
 (
W
)
40
60
80
100
120
140
160
180
 Fig. 2. Confidence intervals of the regression lines of W max as 
function of 6MWD. Regression lines (dashed lines) and their 95% 
confidence intervals (solid lines) for W max as function of 6MWD 
in the obstructive group (black) and the asbestosis group (grey). 
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 We found significant correlations between W max and 
6MWD or related measures in a large population of pa-
tients with four different respiratory disorders in men 
(n = 255). The correlations were weaker than those re-
ported in the literature  [4–8] . This might be explained by 
our less homogeneous but, from a clinical perspective, 
more realistic patient cohort. We aimed to evaluate a 
broad panel of predictors of W max from a statistical point 
of view, but also to analyze subsets of predictors that are 
likely to be available in clinical practice. 
 In patients with obstructive airway diseases compris-
ing asthma, COPD and silicosis, the correlations with 
W max were homogeneous and could be pooled. The prod-
uct of 6MWD and FFM proved to be a better predictor 
than 6MWD itself or than walk work, i.e. the product of 
6MWD and body weight. These findings are in accor-
dance with published data  [12] . Since COPD patients of-
ten exhibit reduced muscle mass relative to body weight, 
the FFM reflects the actual muscle mass better than body 
weight  [4] . 
 The prediction of W max was improved by including 
dyspnea score, FVC and quadriceps muscle force. The 
MMRC is a simple means for assessing the impact of 
breathlessness in daily life. It has been described to be 
correlated with FVC as well as with 6MWD  [13] . 
 Concerning lung function, FVC was the best predic-
tor, independent of the lung disease. In restrictive disor-
ders, vital capacity is directly affected, and thus, a corre-
lation is plausible  [14] . In COPD, the correlation can be 
explained by a reduced inspiratory capacity due to dy-
namic lung hyperinflation  [15, 16] . In advanced COPD, 
dynamic hyperinflation is observed not only in maximal 
exercise testing but also after the 6MWD  [17, 18] .
 In patients with obstructive lung disorders, quadri-
ceps muscle force was an additional predictor of W max . 
Besides lung function impairment and dyspnea, periph-
eral muscle weakness contributes to exercise limitation in 
COPD  [19] . Quadriceps muscle weakness could be shown 
to occur in about 25% of patients with COPD without 
correlation to disease severity  [20] . Quadriceps muscle 
dysfunction can be found not only if FFM is reduced but 
also in some patients with preserved FFM  [21] . 
 Patients with asbestosis, resembling a restrictive lung 
disorder, showed a weaker relationship between W max 
and 6MWD compared to obstructive diseases. Inclusion 
of the FVC and MMRC improved the correlation. 
 Although we have included many predictors, even the 
optimal regression model explained only 57% of variance 
in the obstructive group, and in the asbestosis group 
 ! 50%. Other unknown factors must have contributed to 
this result or the inherent variability of tests plays a role. 
Both 6MWD and W max address exercise tolerance, both 
depending on motivation. While 6MWD is sensitive in 
patients with advanced impairment, its value is limited in 
less impaired patients due to a ceiling effect. This might 
explain part of the variability in the relationship between 
both measures. Problems of coordination may also have 
a different impact. 
 The 6MWD is known to exhibit a learning effect  [22, 
23] . In our data, the first 6MWD was significantly short-
er, whereas the second and third test did not differ statis-
tically. This confirms that one training test is necessary 
to gain reliable results. Eiser et al.  [22] calculated an 8% 
intrasubject variation of 6MWD. In our population, this 
would correspond to a variation between about 18 and 
58 m for the minimum and maximum 6MWD. This also 
limits the accuracy of prediction. A variation of 50 m in 
6MWD would induce a variation of predicted W max of 
11.6 W.  
 The reproducibility of W max is more difficult to assess 
as the test aims at exhaustion. Literature data suggest an 
intrasubject variability of about 10% in COPD  [24–26] . In 
our study, a variability of 10% would correspond to vari-
ations between 4 and 23 W, and about 11.4 W on average. 
The variability of predicted W max as indicated by the re-
sidual SD was much larger. This confirms the assumption 
that the variability in the predictor 6MWD also has an 
impact on the reliability of the predicted W max . As a re-
Table 5. 9 5% prediction intervals of Wmax for a newly studied patient at different levels of the 6MWD
Asthma Silicosis COPD A sbestosis
6MWD, m interval, W 6MWD, m interval, W 6MWD, m interval, W 6MWD, m interval, W
Mean 530 871.4 470 856.2 440 853.5 511 847.4
Upper value 726 873.1 600 858.6 640 856.8 760 849.6
Lower value 270 874.5 250 862.4 230 857.4 300 849.1
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 Fig. 3.  a–f Residuals of predicted W max of COPD patients in com-
parison to residuals of other equations in the literature applied to 
the data set.  a Residuals of data from this study according to equa-
tion (a) (see Results) in the obstructive group (n = 186) versus the 
6MWD.  b–f Residuals, having applied equations from references 
 [4–8] to the data from this study for the obstructive group (n = 
186) versus the 6MWD.  b 103.217 + 30.500 (= male gender) + 
[–1.613  age (years) + (0.002  6MWW [km  kg])]  [7] .  c –51.994 – 
0.505 (= male gender) – [0.234  age (years)] + [0.091  height (cm)] 
+ [0.132  6MWD (m)]  [8] .  d 17.393 + [1.442  6MWW (km  kg)]  [5] . 
 e 2.310  6MWW (km  kg) + 8.820 [6] . f –27.9717 + [3.7792  6MWFFM 
(km  kg)]  [4] . 
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W W
 Fig. 4.  a ,  b Residuals of predicted W max of 
asbestosis patients in comparison to resid-
uals of the equation in the literature for id-
iopathic pulmonary fibrosis patients ap-
plied to the data set.  a Residuals of the 
present data according to equation (e) (see 
Results) in the asbestosis group (n = 69) 
versus the 6MWD.  b Residuals accord-
ing to the equation from reference  [6] 
(0.122  6MWD) + (0.387  FVC %pred.) – 
21.474 applied to our own data, for the as-
bestosis group (n = 69), versus the 6MWD. 
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sult, even in the optimal models, the 95% prediction in-
tervals were wide and the maximally achievable accuracy 
of prediction in single individuals is low. Sillen et al.  [8] 
came to a similar conclusion: even after calculating a re-
gression equation in a COPD cohort of nearly 3,000 pa-
tients using 6MWD, anthropometric parameters and 
FEV 1 as predictors, the estimation of W max was too inac-
curate to be of practical value in an individual. Ross et al. 
 [27] stated a comparable result for the estimation of peak 
oxygen uptake via 6MWD, with data indicating a residu-
al standard error of peak VO 2 as high as 26.7%.
 For clarification and comparison, we also applied pub-
lished prediction equations of W max to our data. Option-
al additional predictors in these studies were age, gender, 
body weight or FFM and FEV 1 . In the obstructive group, 
the residuals of two equations  [7, 8] showed similar vari-
ance and distribution to our equation, with gender being 
part of both equations. However, the other three equa-
tions  [4–6] led to a systemic deviation towards an under-
estimation of W max , getting worse with increasing 
6MWD. In these three studies, gender was not part of the 
equation despite having evaluated a mixed group. Hol-
land et al.  [28] also found considerable differences be-
tween three equations from literature estimating W max 
from 6MWD after applying them to 64 COPD patients; 
in men, the variation reached 47%. Besides the above-
mentioned limited reproducibility of the applied meth-
ods, diverse protocols for cycle ergometer testing and in-
clusion of different predictors may also contribute to the 
identified differences. Only one equation from the litera-
ture  [8] included a lung function parameter. Pretto et al. 
 [29] did not use the 6MWD but baseline respiratory func-
tion as the only predictor of W max ; the correlation was 
0.85. This underlines the importance to include measures 
of lung function impairment when predicting W max . The 
equation for lung fibrosis  [6] has been assessed in an 
Asian population and included FVC as an additional pre-
dictor. The application to our data led to residuals which 
showed a systematic deviation toward lower values inde-
pendent of the 6MWD value, probably caused by differ-
ent anthropometry. 
 Limitations of the Study 
 We included asthma patients who exhibited W max 
 1 200 W. In these patients, the 6MWD might not be an 
appropriate test. Due to the ceiling effect of the walking 
distance, the slope of the prediction equation could be cal-
culated higher than in a more physically impaired cohort. 
 When comparing different prediction equations, the 
underlying study protocols and inclusion criteria may 
differ and comparability may be hampered. In addition, 
the specific populations have to be taken into account. 
Three equations were assessed in Australia and the 
Netherlands, countries with populations that can be re-
garded similar to German anthropometry. In the case of 
the other two equations, based on a Brazilian and an 
Asian population, the value of a comparison to a Euro-
pean population is limited because the anthropometric 
characteristics of the patients may differ considerably. 
This could lead to a different degree of correlation be-
tween the analyzed parameters, as well as to divergent 
slope and intercept of the regression line of the predic-
tion equation.
 Conclusion 
 Our results confirm the possibility to predict W max 
from 6MWD and related measures, but the achievable 
accuracy of prediction in single individuals is too low to 
be of practical value. A replacement of the individual as-
sessment of W max by other tests cannot be advised.
 Despite this, the prediction equations which we estab-
lished on the basis of a large, heterogeneous data set might 
be useful for the estimation of average values in epide-
miological and clinical studies, when cohorts in which 
W max has either been or not been determined are to be 
compared.
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